Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Brain Disorder Suppliers In Europe
6 companies found
based inHengelo, NETHERLANDS
ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997 as a spin-off company of the University of Twente, Enschede. It now has offices located in ...
based inSchiedlberg, AUSTRIA
g.tec medical engineering produces invasive and non-invasive brain-computer interfaces (BCIs) and neurotechnology that are used worldwide to measure and analyze brain waves with the highest possible resolution. A key factor is the real-time data ...
based inHelsinki, FINLAND
Nexstim was established in 2000 to commercialise the opportunity of adding navigation to an existing transcranial magnetic stimulation (TMS) technology. The founders believed that navigation and making the TMS visible with the help of navigation is ...
Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key ...
based inMunich, GERMANY
The technological progress made in biomedical research has radically changed the view to new treatment strategies. Modern genetic technologies can deliver disease-relevant targets but are insufficient to refill the empty drug discovery pipeline. We ...
based inOrsay, FRANCE
Sophysa started operations in 1976 in France, and set a significant milestone in 1985 with the introduction of the world’s first programmable valve Sophy. This represented a major advance in the treatment of hydrocephalus. The development of the ...
based inBarcelona, SPAIN
We are developing the next generation of neuroelectronic therapies powered by machine learning. Our graphene-brain interfaces have the capability of reading at a resolution never seen before, as well as detecting therapy-specific biomarkers and ...